If you need more lookups,
subscriptions start at $34 USD/month.
Bryan Goodwin Location
Boston, MA, US
Bryan Goodwin Work
2026 -now Chief Scientific Officer at NewCo @ None
2025 -2026 Vice President - Cardiorenal Strategy and Portfolio @ Eli Lilly and Company
2023 -2025 Senior Vice President, Head of Biology and Translational Sciences @
2017 -2023 Vice President, Head of Biology @
2016 -2017 Senior Director, Head of Gastrointestinal, Metabolic, and Endocrine Research Therapeutic Area @
2014 -2016 Senior Director, Muscle Metabolism, Cardiovascular and Metabolic Disease Research Unit @
2013 -2014 Director, Diabetes Prevention and Remission Group, Cardiovascular and Metabolic Disease Research Unit @
2008 -2013 Lab head, Cardiovascular and Metabolic Disease Research Unit @
1999 -2008 Manager @
1999 -2008 Manager @
Bryan Goodwin Education
University of Sydney
Doctor of Philosophy (Ph.D.), Cell/Cellular and Molecular Biology
1996-1999
Bryan Goodwin Skills
Drug Discovery
Drug Development
Pharmacology
Clinical Development
In Vitro
In Vivo
Lifesciences
Pharmaceutical Industry
Biomarkers
Biotechnology
Assay Development
Oncology
Public Speaking
Microsoft Office
PowerPoint
Molecular Biology
Leadership
Project Management
Microsoft Word
Bryan Goodwin Summary
Bryan Goodwin, based in Boston, MA, US, is currently a Chief Scientific Officer at NewCo at None. Bryan Goodwin brings experience from previous roles at Eli Lilly and Company, Morphic Therapeutic, Enanta Pharmaceuticals and Shire. Bryan Goodwin holds a 1996 - 1999 Doctor of Philosophy (Ph.D.), Cell/Cellular and Molecular Biology @ University of Sydney. With a robust skill set that includes Drug Discovery, Drug Development, Pharmacology, Clinical Development, In Vitro and more. Bryan Goodwin has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Bryan Goodwin?
Find contact details for 700 million professionals.